In this study, we aimed to establish the mechanisms whereby peroxisome proliferator\u96activated receptor (PPAR) agonism brings about redistribution of fat toward subcutaneous depots and away from visceral fat. In rats treated with the full PPAR agonist COOH (30 mg \ub7 kg\u961 \ub7 day\u961) for 3 weeks, subcutaneous fat mass was doubled and that of visceral fat was reduced by 30% relative to untreated rats. Uptake of triglyceride-derived nonesterified fatty acids was greatly increased in subcutaneous fat (14-fold) and less so in visceral fat (4-fold), with a concomitant increase, restricted to subcutaneous fat only, in mRNA levels of the uptake-, retention-, and esterification-promoting enzymes lipoprotein lipase, aP2, and diacylglycerol...
In this study, we defined the role of peroxisome proliferator-activated receptor beta/delta (PPARdel...
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, regu...
Peroxisome proliferators are a diverse group of compounds that cause hepatic hypertrophy and hyperpl...
In this study, we aimed to establish the mechanisms whereby peroxisome proliferator–activated recept...
This study sought to determine whether the adipose depotspecific (subcutaneous [SF] vs. visceral [VF...
Dietary fatty acids (FAs) affect certain metabolic routes, including pathways controlled by the pero...
AbstractIn contrast to the well-established roles of PPARγ and PPARα in lipid metabolism, little is ...
OBJECTIVE—Pharmacological use of peroxisome proliferator– activated receptor (PPAR) agonists and tr...
Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic dysfunc...
Background: The nuclear receptors peroxisome proliferator-activated receptor γ (PPARγ) and peroxisom...
<div><p>Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic...
International audiencePeroxisome proliferator-activated receptors (PPARs) are nuclear receptors acti...
It has been more than three decades since peroxisome proliferator-activated receptors (PPARs) were f...
agonists lower circulating lipids, but the consequences for muscle lipid metabolism and insulin sens...
AbstractThe peroxisome proliferator-activated receptors (PPARs) are ligand activated nuclear recepto...
In this study, we defined the role of peroxisome proliferator-activated receptor beta/delta (PPARdel...
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, regu...
Peroxisome proliferators are a diverse group of compounds that cause hepatic hypertrophy and hyperpl...
In this study, we aimed to establish the mechanisms whereby peroxisome proliferator–activated recept...
This study sought to determine whether the adipose depotspecific (subcutaneous [SF] vs. visceral [VF...
Dietary fatty acids (FAs) affect certain metabolic routes, including pathways controlled by the pero...
AbstractIn contrast to the well-established roles of PPARγ and PPARα in lipid metabolism, little is ...
OBJECTIVE—Pharmacological use of peroxisome proliferator– activated receptor (PPAR) agonists and tr...
Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic dysfunc...
Background: The nuclear receptors peroxisome proliferator-activated receptor γ (PPARγ) and peroxisom...
<div><p>Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic...
International audiencePeroxisome proliferator-activated receptors (PPARs) are nuclear receptors acti...
It has been more than three decades since peroxisome proliferator-activated receptors (PPARs) were f...
agonists lower circulating lipids, but the consequences for muscle lipid metabolism and insulin sens...
AbstractThe peroxisome proliferator-activated receptors (PPARs) are ligand activated nuclear recepto...
In this study, we defined the role of peroxisome proliferator-activated receptor beta/delta (PPARdel...
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, regu...
Peroxisome proliferators are a diverse group of compounds that cause hepatic hypertrophy and hyperpl...